International Experience and Enlightenment of HTA in Consumables Access and Payment

doi:10.19546/j.issn.1674-3830.2022.4.026

China Health Insurance ›› 2022, Vol. 0 ›› Issue (4) : 118-122. DOI: 10.19546/j.issn.1674-3830.2022.4.026

International（ Region) Comparison

International Experience and Enlightenment of HTA in Consumables Access and Payment

Author information +

History +

Abstract

Health Technology Assessment (HTA) has been widely used in the assessment, medical insurance list negotiation and reimbursement policy making of consumables. This study focuses on the process and experience of applying HTA into healthcare consumables access and payment in the UK and Australia, and intends to provide reference for HTA policy making in the future.

Key words

HTA / medical consumables / international experience / policy enlightenment

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

International Experience and Enlightenment of HTA in Consumables Access and Payment[J]. China Health Insurance. 2022, 0(4): 118-122 https://doi.org/10.19546/j.issn.1674-3830.2022.4.026

References

[1] 众成医械,年度数据盘点:2020年全国医疗器械生产企业数量达25440[EB/OL].https://www.cn-healthcare.com/articlewm/20210108/content-1178817.html, 2021-01-08/2022-01-18.
[2] 明坚,魏艳,何运臻,等. 医疗器械和诊断产品的卫生技术评估路在何方 ——基于国际经验的启示[J]. 中国医疗保险,2021(6):69-74. DOI:10.19546/j.issn.1674-3830.2021.6.019.
[3] Australia Department of Health Private Health Unit, Overview of Health System[EB/OL].https://www.privatehealth.gov.au/health_insurance/what_is_covered/index.htm,2021-11/2022-01-18.
[4] 杜雯雯,徐伟,何仁鑫,张圣和,贾佳佳.澳大利亚医疗服务价格形成机制及启示[J].中国卫生经济,2021,40(2):93-96.
[5] Australia Department of Health, Medicare[EB/OL].https://www.servicesaustralia.gov.au/individuals/medicare2021-10-10/2022-01-18
[6] Department of Health. Overview of medical devices and IVD regulation[EB/OL].Australia;2021 https://www.tga.gov.au/sme-assist/medical-devices-regulation-introduction, 2022-01-18.
[7] Medical services advisory committee, Australian Government HTA Processes[EB/OL].http://www.msac.gov.au/internet/msac/publishing.nsf/Content/Factsheet-02, 2016-6-29/2022-01-18
[8] Department of Health. Listing on the Prostheses List byMedical Technology Association of Australia[EB/OL].Australia;Department of Health;2021 https://www.mtaa.org.au/listing-prostheses-list,2022-01-18.
[9] 邱英鹏,赵羽西,赵翔,等.澳大利亚假体类高值医用耗材医保准入管理经验及启示[J].中国卫生质量管理,2021,28(5):4.
[10] 张小娟,朱坤.英国卫生服务购买经验及启示[J].中国全科医学,2021,24(22):8.
[11] Medicines and Healthcare products Regulatory Agency. Regulating medical devices in the UK[EB/OL].2021 https://www.gov.uk/guidance/regulating-medical-devices-in-the-uk,2022-01-18.
[12] 吕兰婷,余浏洁.英国NICE医用耗材准入流程及启示[J].中国医疗保险,2019(10):4.
[13] National Institute for Health and Care Excellence. Medical Technologies Evaluation Programme: Methods Guide [EB/OL].https://www.ncbi.nlm.nih.gov/books/NBK395861/, 2022-01-18.
[14] Doncaster and Bassetlaw NHS.Selection and Procurement of Medical Devices Policy (2021)[EB/OL].https://www.dbth.nhs.uk/document/corpproc3-3/, 2022-01-18.
[15] Walker A, Dale C, Curran N,et al.Leading the spread and adoption of innovation at scale: an Academic Health Science Network's perspective[J].BMJ Leader 2021;5:155-158.
[16] National Institute for Health and Care Excellence. Single technology appraisal (STA) timeline [EB/OL].https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/technology-appraisal-guidance/process/sta-timeline, 2021-07-05.
[17] 王海银,陈珉惺,何江江,何达,金春林.医院技术评估的应用价值及在我国的发展策略[J].中国卫生资源,2018,21(2):83-85.